Widespread adoption of anti-obesity medications is influencing consumer purchasing behavior across North America and Europe. Volume sales of high-calorie packaged foods declined 2.4 percent in test markets with elevated prescription density.
Product Line Reformulation
Consumer packaged goods companies are accelerating capital expenditure into high-protein, low-density nutritional products. Strategic acquisitions of specialized health brands have increased 30 percent year-to-date as legacy food manufacturers adapt.